Skip to main content

State Board Of Administration Of Florida Retirement System

Source: SEC Form 13F · as of Mar 2026

State Board Of Administration Of Florida Retirement System holds 88 biotech & pharma companies tracked by BioSniper, totaling $438.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

88

Total value held

$438.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,089,033$151.8M
REGNREGENERON PHARMACEUTICALS, INC.89,974$69.5M
ALNYALNYLAM PHARMACEUTICALS, INC.112,718$37.3M
INSMINSMED Inc180,405$29.5M
MRNAModerna, Inc.302,114$15.3M
RVMDREVOLUTION MEDICINES, INC.144,882$14.1M
INCYIncyte Corp.149,611$14.1M
EXELEXELIXIS, INC.270,598$11.6M
IONSIONIS PHARMACEUTICALS INC135,878$10.2M
BMRNBIOMARIN PHARMACEUTICAL INC162,368$9.2M
ROIVRoivant Sciences Ltd.325,757$9.0M
JAZZJazz Pharmaceuticals plc38,508$7.3M
APLSApellis Pharmaceuticals, Inc.96,125$3.9M
VKTXViking Therapeutics, Inc.95,034$3.1M
ACADACADIA PHARMACEUTICALS INC128,689$2.9M
BBIOBridgeBio Pharma, Inc.33,388$2.5M
SUPNSUPERNUS PHARMACEUTICALS, INC.40,322$2.1M
TEVATeva Pharmaceutical Industries Limited63,829$1.9M
CYTKCYTOKINETICS INC28,486$1.9M
ARWRARROWHEAD PHARMACEUTICALS, INC.29,649$1.9M
SMMTSummit Therapeutics Inc.96,009$1.8M
PBYIPUMA BIOTECHNOLOGY, INC.272,890$1.7M
PTGXProtagonist Therapeutics, Inc16,303$1.7M
PCVXVaxcyte, Inc.28,102$1.6M
AXSMAxsome Therapeutics, Inc.9,064$1.5M
NUVLNuvalent, Inc.14,317$1.5M
PTCTPTC THERAPEUTICS, INC.20,211$1.4M
OGNOrganon & Co.225,178$1.3M
FOLDAMICUS THERAPEUTICS, INC.88,119$1.3M
RYTMRHYTHM PHARMACEUTICALS, INC.14,650$1.3M
TGTXTG THERAPEUTICS, INC.37,685$1.3M
TERNTerns Pharmaceuticals, Inc.20,516$1.1M
COGTCogent Biosciences, Inc.27,707$1.1M
SRRKScholar Rock Holding Corp19,747$971K
APGEApogee Therapeutics, Inc.9,350$787K
LGNDLigand Pharmaceuticals Incorporated3,805$760K
DNTHDianthus Therapeutics, Inc. /DE/8,591$721K
ADMAADMA BIOLOGICS, INC.78,823$710K
SIGASIGA TECHNOLOGIES INC131,626$704K
SYRESpyre Therapeutics, Inc.13,905$701K
DNLIDenali Therapeutics Inc.34,168$656K
TVTXTravere Therapeutics, Inc.20,785$618K
KODKodiak Sciences Inc.15,103$576K
BEAMBeam Therapeutics Inc.23,870$569K
IRONDisc Medicine, Inc.8,704$557K
AGIOAGIOS PHARMACEUTICALS, INC.15,847$536K
LQDALiquidia Corp13,680$516K
ADPTAdaptive Biotechnologies Corp35,558$494K
ARQTArcutis Biotherapeutics, Inc.20,547$484K
CLDXCelldex Therapeutics, Inc.14,537$461K
TNGXTango Therapeutics, Inc.21,051$440K
VCELVericel Corp13,599$437K
INVAInnoviva, Inc.17,702$412K
ELVNEnliven Therapeutics, Inc.10,480$411K
NTLAIntellia Therapeutics, Inc.31,268$401K
IMVTImmunovant, Inc.15,774$392K
ZYMEZymeworks Inc.15,340$384K
DAWNDay One Biopharmaceuticals, Inc.17,880$383K
ARDXARDELYX, INC.60,780$364K
ORKAOruka Therapeutics, Inc.6,687$328K
RCUSArcus Biosciences, Inc.15,072$326K
ANIPANI PHARMACEUTICALS INC3,995$307K
ANABANAPTYSBIO, INC5,526$306K
SLNOSOLENO THERAPEUTICS INC9,041$303K
ALMSALUMIS INC.13,604$300K
STOKStoke Therapeutics, Inc.9,089$296K
HROWHARROW, INC.8,360$295K
IBRXImmunityBio, Inc.37,521$288K
CAPRCAPRICOR THERAPEUTICS, INC.9,239$281K
NRIXNurix Therapeutics, Inc.17,611$273K
OCULOCULAR THERAPEUTIX, INC31,418$266K
RLAYRelay Therapeutics, Inc.25,807$257K
VRDNViridian Therapeutics, Inc.\DE12,080$236K
IOVAIOVANCE BIOTHERAPEUTICS, INC.65,451$230K
XERSXeris Biopharma Holdings, Inc.37,970$220K
GERNGERON CORP142,122$212K
OPKOPKO HEALTH, INC.176,260$201K
KURAKura Oncology, Inc.22,684$184K
ARVNARVINAS, INC.16,930$179K
NUVBNuvation Bio Inc.41,690$179K
ABUSArbutus Biopharma Corp35,820$161K
BHVNBiohaven Ltd.18,006$152K
PRTAPROTHENA CORP PUBLIC LTD CO15,386$150K
ORICOric Pharmaceuticals, Inc.11,310$143K
RXRXRECURSION PHARMACEUTICALS, INC.45,810$141K
RGNXREGENXBIO Inc.11,615$97K
SANASana Biotechnology, Inc.26,678$77K
AVXLANAVEX LIFE SCIENCES CORP.20,345$62K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.